Skip to content

Nationwide surveillance by the surveillance committee of Japanese Society of Chemotherapy, Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology and the Japanese Society for Infection Prevention and Control - Complicated urinary tract infection 2025-

Nationwide surveillance by the surveillance committee of Japanese Society of Chemotherapy, Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology and the Japanese Society for Infection Prevention and Control - Complicated urinary tract infection 2025- - Nationwide surveillance of complicated urinary tract infection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000061147
Enrollment
800
Registered
2026-04-03
Start date
2025-11-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complicated urinary tract infection

Interventions

None listed

Sponsors

The Committee of Four Academic Societies Joint Antimicrobial Susceptibility Surveillance Program
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Complicated urinary tract infection

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Antimicrobial susceptibility of causative bacteria isolated from complicated urinary tract infection

Countries

Japan

Contacts

Public ContactMitsuru Yasuda

Sapporo Medical University School of Medicine, Department of Infection Control & Laboratory Medicine

yasuda7jpe@sapmed.ac.jp0116112111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026